Dialysis world news


Race to raise kidney funds - Swindon Advertiser PDF Print
Swindon Advertiser
The 22-year-old, of Taw Hill, who is a student at the University of Reading, was inspired after working with patients in the renal unit during the summer holidays as part of his placement. He said: “I have been doing voluntary projects in hospital

...

 
FDA Approves Updated Label For Merck's Vytorin - Update - NASDAQ PDF Print
NASDAQ
Merck noted that in the Study of Heart and Renal Protection or SHARP, Vytorin 10/20 mg lowered LDL cholesterol or bad cholesterol in patients with moderate to severe chronic kidney disease, and major vascular events were reduced in the treatment group ...
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes

...

 
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes ... - MarketWatch (press release) PDF Print
MarketWatch (press release)
Approximately one-third of the patients were undergoing dialysis therapy for end-stage renal disease at the time of entry, and the remaining patients were pre-dialysis patients with advanced CKD with a median estimated glomerular filtration rate (GFR,

...

 
Bottom 5 Companies in the Health Care Equipment Industry with the Lowest ... - Financial News Network Online PDF Print
Financial News Network Online
NxStage Medical, Inc. is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. The Company's primary product, the NxStage System One, is a small,

...

 
SCB to screen people for kidney diseases - IBNLive.com PDF Print
IBNLive.com
CUTTACK: The Nephrology department of the SCB Medical College and Hospital in association with the district health administration is set to embark on an intensive screening of the people in pockets across Narsinghpur and Baramba blocks of Cuttack

...

 
<< Start < Prev 521 522 523 524 525 526 527 528 529 530 Next > End >>

Page 527 of 2630
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.